Enhancing preclinical drug discovery with artificial intelligence

被引：42
|
作者：
Vijayan, R. S. K. [1 ]
Kihlberg, Jan [2 ]
Cross, Jason B. [1 ]
Poongavanam, Vasanthanathan [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA
[2] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden
来源：
DRUG DISCOVERY TODAY | 2022年 / 27卷 / 04期
关键词：
Artificial intelligence; Machine learning; Deep learning; Drug discovery; LIGAND BINDING-AFFINITY; ACCURATE PREDICTION; NEURAL-NETWORKS; DOCKING; COMPUTER; OPTIMIZATION; QUALITY; DESIGN; MODELS; GUIDE;
D O I：
10.1016/j.drudis.2021.11.023
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Artificial intelligence (AI) is becoming an integral part of drug discovery. It has the potential to deliver across the drug discovery and development value chain, starting from target identification and reaching through clinical development. In this review, we provide an overview of current AI technologies and a glimpse of how AI is reimagining preclinical drug discovery by highlighting examples where AI has made a real impact. Considering the excitement and hyperbole surrounding AI in drug discovery, we aim to present a realistic view by discussing both opportunities and challenges in adopting AI in drug discovery.
引用
收藏
页码：967 / 984
页数：18
相关论文
共 50 条
  • [41] Drug discovery in the context of precision medicine and artificial intelligence
    Hasanzad, Mandana
    Nosrati, Marzieh
    Khatami, Fatemeh
    Rahmani, Parham
    Sarhangi, Negar
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    [J]. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2024, 9 (01): : 42 - 53
  • [42] Artificial intelligence for high content imaging in drug discovery
    Carreras-Puigvert, Jordi
    Spjuth, Ola
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2024, 87
  • [43] Artificial intelligence for drug discovery and in Alzheimer's disease
    Qiu, Yunguang
    Cheng, Feixiong
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2024, 85
  • [44] Artificial Intelligence in Drug Discovery: Into the Great Wide Open
    Bajorath, Jurgen
    Kearnes, Steven
    Walters, W. Patrick
    Meanwell, Nicholas A.
    Georg, Gunda I.
    Wang, Shaomeng
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (16) : 8651 - 8652
  • [45] Artificial intelligence in cancer target identification and drug discovery
    Yujie You
    Xin Lai
    Yi Pan
    Huiru Zheng
    Julio Vera
    Suran Liu
    Senyi Deng
    Le Zhang
    [J]. Signal Transduction and Targeted Therapy, 7
  • [46] Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
    Moreira-Filho, Jose T.
    Silva, Arthur C.
    Dantas, Rafael F.
    Gomes, Barbara F.
    Souza Neto, Lauro R.
    Brandao-Neto, Jose
    Owens, Raymond J.
    Furnham, Nicholas
    Neves, Bruno J.
    Silva-Junior, Floriano P.
    Andrade, Carolina H.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] Artificial Intelligence for Computer-Aided Drug Discovery
    Kate, Aditya
    Seth, Ekkita
    Singh, Ananya
    Chakole, Chandrashekhar Mahadeo
    Chauhan, Meenakshi Kanwar
    Singh, Ravi Kant
    Maddalwar, Shrirang
    Mishra, Mohit
    [J]. DRUG RESEARCH, 2023, 73 (07) : 369 - 377
  • [48] The Potential Applications of Artificial Intelligence in Drug Discovery and Development
    Farghali, Hassan
    Kutinova Canova, Nikolina
    Arora, Mahak
    [J]. PHYSIOLOGICAL RESEARCH, 2021, 70 : S715 - S722
  • [49] Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?
    Zhavoronkov, Alex
    Vanhaelen, Quentin
    Oprea, Tudor I.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 780 - 785
  • [50] Exploring Artificial Intelligence in Drug Discovery: A Comprehensive Review
    Bijral, Rajneet Kaur
    Singh, Inderpal
    Manhas, Jatinder
    Sharma, Vinod
    [J]. ARCHIVES OF COMPUTATIONAL METHODS IN ENGINEERING, 2022, 29 (04) : 2513 - 2529
12345